FDA grants Strides Pharma approval for Amantadine Hydrochloride Softgel Capsules 100mg
The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Symmetrel Capsules, 100 mg, of Endo Pharmaceuticals, Inc. Strides Pharma Science Limited announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte Limited, Singapore, has received approval for Amantadine Hydrochloride Softgel Capsules USP, 100mg from the United States Food & Drug Administration (US FDA). The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Symmetrel Capsules, 100 mg, of Endo Pharmaceuticals, Inc. Biological E receives DCGI approval for administration of Warburg Pincus to invest $ 210 million in medical devices firm Meril Kolkata: Pvt hosps stare at wastage of vax, some plan free shots After 2 years, regular international flights may resume from next month Pharma strides pharma Symmetrel Capsules Health news FDA Endo Pharmaceuticals Amantadine Hydrochloride Softgel Capsules According to IQVIA MAT December 2021 data, the US market for Amantadine Hydrochloride Capsules USP,100mg is approximately $11 million. The product will be manufactured at the company
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!